safety and efficacy evaluation of 5 cosmetic formulations on 26 healthy human subjects.

Indian Institute of Technology Bombay0 个研究点目标入组 26 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Volunteer (female and male) in generally good health.
•2.Volunteer between the ages of 18 and 50 years.
•3.Volunteer has not participated in a similar clinical studies in the past three months.
•4.Volunteer willing to give a written Informed Consent, also agrees under audio-video consenting procedures and should come for regular three visits after patch application.
•5.Volunteer with fair skin will be preferred.
•6.Volunteer with clear back.
•7.UPT test should be negative for female volunteer at the time of screening.

•1.Known history or present condition of allergic response to any cosmetic products.
•2.Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings.
•3.Medications (e.g. steroids or antihistamines), which would compromise the study.
•4.Under the influence of alcohol.
•5.Pregnant or lactating women.
•6.Any history of underlying uncontrolled medical illness including diabetes, liver disease or any other serious medical illness
•7.Volunteers participating in any other cosmetics related clinical trials or any other clinical trial.
•8.Hypersensitivity to any of the tested products.
•9.Use of Hormonal Contraceptives either Oral or Implants.
•10.Any other

发起方

Indian Institute of Technology Bombay